Heghine Khachatryan: World Federation of Hemophilia Is Far More Than An Organization
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from WFH on LinkedIn:
”WFH’s work consistently reinforces a critical truth:
bleeding disorders are not only medical conditions — they are issues of health equity, gender equity, and human rights.
-For clinicians, WFH represents knowledge, standards, and professional growth
-For patients, it provides voice, visibility, and dignity
– For health systems, it offers a sustainable model for organizing rare disease care.
World Federation of Hemophilia (WFH) is far more than an organization — it is a global movement that has fundamentally transformed the lives of people living with hemophilia and other inherited bleeding disorders worldwide.
As 2025 comes to a close, WFH’s impact is particularly evident in several key areas:
• increasing global awareness of hemophilia and bleeding disorders,
• addressing the long-standing underdiagnosis of bleeding disorders in women and girls,
• strengthening continuous medical education for healthcare professionals,
• advancing laboratory standards, clinical guidelines, and evidence-based care, and
• expanding equitable access to safe and effective treatment.
With gratitude for WFH’s global leadership, collaboration, and unwavering commitment to patient-centered care.”
Qutoing World Federation of Hemophilia‘s post:
”As 2025 comes to a close, the World Federation of Hemophilia is celebrating a year of meaningful progress for people with hemophilia and Bleeding Disorders around the world.
Thanks to our global community, partners, and volunteers, this year saw important milestones, from expanding diagnosis and care to strengthening humanitarian aid and advancing treatment standards.
Read more.
Wishing our community a bright start to 2026, we look forward to connecting with you in Malaysia for the WFH 2026 World Congress!”

Stay updated with Hemostasis Today.
-
Jul 14, 2026, 10:24Sara Zalghout: The Little Things That Make ISTH 2026 Special
-
Jul 14, 2026, 10:11Joseph R. Shaw: GAUGE Advances FXa Inhibitor Reversal at ISTH 2026
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026